KOSDAQ-listed QuantaMatrix was strong early on the 26th. The share rise is seen as driven by the company's statement that it resolved financial risk through large-scale fundraising.
As of 9:34 a.m. that day, QuantaMatrix was trading at 4,825 won, up 325 won (7.22%) from the previous session.
Microbial diagnostics developer QuantaMatrix said before the regular session opened that day that it could eliminate the risk of being designated for administrative issues due to "loss from continuing operations before income taxes," which the market had worried about, through a 36 billion won capital raise.
On the 22nd, QuantaMatrix disclosed that it had decided to issue 36 billion won of perpetual convertible bonds. (☞ "MiCo becomes a big hand in M&A… This time it invests in the bioventure QuantaMatrix founded by Professor Kwon Seong-hun")
These perpetual convertible bonds are fully recognized as equity on the books. The acquirer is PentaStone Fund No. 3 New Technology Investment Association, 99% owned by listed company MiCo.
A QuantaMatrix official said, "Not only has the commercialization of dRAST progressed, but the publication of a paper on uRAST in Nature and large-scale funding from the U.S. government (CARB-X) have already completed technical validation," adding, "With this fundraising removing the loss-before-tax and administrative designation risks that the market was concerned about, the company's value could be reassessed."